Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders (vol 55, pg 330, 2018)

被引：0
|
作者：
Kocaman, Gulsen [1 ]
Kahraman, Nese [2 ]
Gurkan Koseoglu, Banu [2 ]
Bilgic, Basar [3 ]
Matur, Zeliha [4 ]
Ertas, Mustafa [5 ]
Gulsen, Yesim [3 ]
Baykan, Betul [3 ]
机构：
[1] Bezmialem Vakif Univ, Dept Neurol, Fac Med, Istanbul, Turkey
[2] Istanbul Univ, Istanbul Fac Dent, Dept Maxillofacial Surg, Istanbul, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey
[4] Istanbul Bilim Univ, Dept Neurol, Fac Med, Istanbul, Turkey
[5] Private Off, Neurol, Istanbul, Turkey
来源：
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY | 2019年 / 56卷 / 01期
关键词：
D O I：
10.29399/npa.23634
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [21] Wearing-off effect of onabotulinumtoxina in chronic migraine: Evaluation in a series of 117 patients
    Navarrete Perez, J. J.
    Ruiz Pinero, M.
    de San Roman, C. Gomez Lopez
    Juanatey, A.
    Blanco, L.
    Moreno, R.
    Guerrero, A. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 547 - 547
  • [22] Predictors of Early Treatment Response in Patients with Chronic Migraine Receiving OnabotulinumtoxinA Injection Therapy
    Rothrock, J.
    Curreri, T.
    Andress-Rothrock, D.
    Lopez, J.
    HEADACHE, 2014, 54 (08): : 1429 - 1429
  • [23] Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
    Vikelis, Michail
    Argyriou, Andreas A.
    Dermitzakis, Emmanouil V.
    Spingos, Konstantinos C.
    Makris, Nikolaos
    Kararizou, Evangelia
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [24] Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
    Michail Vikelis
    Andreas A. Argyriou
    Emmanouil V. Dermitzakis
    Konstantinos C. Spingos
    Nikolaos Makris
    Evangelia Kararizou
    The Journal of Headache and Pain, 2018, 19
  • [25] Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine
    Bekir Enes Demiryurek
    Devrimsel Harika Ertem
    Atilla Tekin
    Mustafa Ceylan
    Yesim Guzey Aras
    Belma Dogan Gungen
    Neurological Sciences, 2016, 37 : 1779 - 1784
  • [26] Effects of onabotulinumtoxinA treatment on efficacy, depression, anxiety, and disability in Turkish patients with chronic migraine
    Demiryurek, Bekir Enes
    Ertem, Devrimsel Harika
    Tekin, Atilla
    Ceylan, Mustafa
    Aras, Yesim Guzey
    Gungen, Belma Dogan
    NEUROLOGICAL SCIENCES, 2016, 37 (11) : 1779 - 1784
  • [27] Reversion of patients with chronic migraine to an episodic migraine classification with fremanezumab treatment (vol 19, P7, 2018)
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez Campos, Verena
    Singh, Rashmi B. Halker
    Ailani, Jessica
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [28] Treatment of orofacial pain and temporomandibular disorders (vol 3, pg 184, 1996)
    Binderman, AF
    Singer, MT
    CURRENT OPINION IN PERIODONTOLOGY, 1997, 4 : 144 - 150
  • [29] The impact of fremanezumab on medication overuse in patients with chronic migraine (vol 19, pg P12, 2018)
    Silberstein, Stephen D.
    Ashina, Sait
    Katsarava, Zaza
    Bibeau, Kristen
    Seminerio, Michael J.
    Harlow, Danielle E.
    Cohen, Joshua M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [30] Efficacy and Tolerability of CGRP Monoclonal Antibody Medications in Patients With Chronic Migraine Undergoing Treatment With OnabotulinumtoxinA
    Cohen, F.
    Armand, C. E.
    Vollbracht, S. E.
    HEADACHE, 2020, 60 : 13 - 13
12345